Search

  • HOME
  • Search
Original Article
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn
Clin Mol Hepatol. 2020;26(3):352-363.   Published online May 28, 2020
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh
Clin Mol Hepatol. 2017;23(4):331-339.   Published online September 26, 2017
Editorial
Lamivudine: fading into the mists of time
Jonggi Choi, Young-Suk Lim
Clin Mol Hepatol. 2017;23(4):314-315.   Published online November 28, 2017
Original Article
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol. 2017;23(3):230-238.   Published online June 30, 2017
Original Article
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clin Mol Hepatol. 2016;22(2):241-249.   Published online June 15, 2016
1284
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park
Clin Mol Hepatol. 2016;22(1):152-159.   Published online March 28, 2016
Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim
Clin Mol Hepatol. 2015;21(2):131-140.   Published online June 26, 2015
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa
Clin Mol Hepatol. 2015;21(1):41-48.   Published online March 25, 2015
Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee
Clin Mol Hepatol. 2014;20(3):267-273.   Published online September 25, 2014
Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang
Clin Mol Hepatol. 2014;20(2):168-176.   Published online June 30, 2014
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol. 2013;19(4):409-416.   Published online December 28, 2013
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
Clin Mol Hepatol. 2013;19(3):273-279.   Published online September 30, 2013
Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun
Clin Mol Hepatol. 2011;17(4):261-267.   Published online December 26, 2011
3
Efficacy of 48-week clevudine therapy for chronic hepatitis B
Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D., Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D., Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.
Clin Mol Hepatol. 2009;15(3):331-337.   Published online September 30, 2009
Long-term clevudine therapy in nucleos(t)ide-naive and Lamivudine-experienced patients with hepatitis B virus-related chronic Liver diseases
Heon Ju Lee, M.D., Jong Ryul Eun, M.D., Chang Hyeong Lee, M.D. Jae Seok Hwang, M.D. Jeong Ill Suh, M.D. Byung Seok Kim, M.D. Byoung Kuk Jang, M.D. Departments of
Clin Mol Hepatol. 2009;15(2):179-192.   Published online June 30, 2009
Comparison of Lamivudine-induced HBsAg Loss rate according to age in children with chronic hepatitis B
Jung Mi Kim , Byung Ho Choe , Mi Ae Chu , Seung Man Cho
Clin Mol Hepatol. 2009;15(2):168-178.   Published online June 30, 2009
Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, Lamivudine-resistant chronic hepatitis B patients
Hyun Wook Jung , Moon Seok Choi , Kap Hyun Kim , Sung Hyun Park , Keum Yeon Kwak , Joon Hyoek Lee , Kwang Cheol Koh , Seung Woon Paik , Byung Chul Yoo
Clin Mol Hepatol. 2009;15(1):52-58.   Published online March 31, 2009
4
A case report of treatment with pegylated interferon alpha for Lamivudine-resistant chronic hepatitis B virus infection
Won Haing Hur , Hyun Young Woo , Soung Won Jeong , Chan Ran You , Si Hyun Bae , Jong Young Choi , Seung Kew Yoon
Clin Mol Hepatol. 2008;14(4):513-518.   Published online December 31, 2008
3
The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with Lamivudine-resistant chronic hepatitis B infection
Jae Hyeon Moon , Mong Cho , Ki Tae Yoon , Jung Ho Bae , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song
Clin Mol Hepatol. 2008;14(4):503-512.   Published online December 31, 2008
7
The Korean Journal of Entecavir 1 mg therapy for Lamivudine-refractory chronic hepatitis B
Hyung Joon Kim
Clin Mol Hepatol. 2008;14(3):411-416.   Published online September 30, 2008
3
Hepatitis B core antigen expression pattern predicts response to Lamivudine therapy in patients with chronic hepatitis B
Kyeh Dong Shi, M.D., Seong Gyu Hwang, M.D., Ju Hyun Choi, M.D., Il Joon Hwang, M.D., Jai Ho Yoon, M.D., Kwang Il Kim, M.D. Chang-Il Kwon, M.D., Sung Pyo Hong, M.D., Pil Won Park, M.D., Kyu Sung Rim, M.D.
Clin Mol Hepatol. 2008;14(2):197-205.   Published online June 20, 2008
Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients
Jin Hee Cho, M.D., Jae Youn Cheong, M.D., Joon Koo Kang, M.D., Jin Sun Park, M.D., Myoung Hee Lee, M.D., Nam Kyu Lim, M.D., Sun Pyo Hong. Soo-Ok Kim. Wang Don Yoo. and Sung Won Cho, M.D.
Clin Mol Hepatol. 2008;14(1):58-66.   Published online March 20, 2008
Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment
Jae Kwon Jung, M.D., Chang Hyeong Lee, M.D., Eun Young Kim, M.D., Jin Tae Jung, M.D., Joon Hyuck Choi, M.D., Ji Min Han, M.D., Myoung In Jin, M.D., Ju Yeon Cho, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.
Clin Mol Hepatol. 2007;13(4):513-520.   Published online December 20, 2007
Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B
In Hee Kim , Seong Hun Kim , Hyun Chul Kim , Kyoung Deok Shin , Sang Wook Kim , Seong Ok Lee , Soo Teik Lee , Dae Ghon Kim
Clin Mol Hepatol. 2007;13(3):349-362.   Published online September 20, 2007
1 | 2 | 3 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 586
TOTAL : 868419
Close layer